FibroGen Inc (FGEN)
0.40
+0.05
(+13.09%)
USD |
NASDAQ |
Dec 20, 16:00
0.4048
0.00 (0.00%)
After-Hours: 20:00
FibroGen Total Liabilities (Quarterly): 466.12M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 1.438B |
| Arbutus Biopharma Corp | 33.55M |
| GlycoMimetics Inc | 4.322M |
| Cidara Therapeutics Inc | 46.70M |
| Cue Biopharma Inc | 19.44M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 264.42M |
| Shareholders Equity (Quarterly) | -243.67M |
| Debt to Equity Ratio | -0.2987 |
| Current Ratio | 1.283 |
| Net Debt Paydown Yield | -0.68% |